NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 28 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 10 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 10 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 10 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FNY Investment Advisers, LLC | 199,220 | $151,000 | 0.12% |
| Allred Capital Management, LLC | 20,528 | $15,000 | 0.01% |
| PATHSTONE FAMILY OFFICE, LLC | 10,050 | $8,000 | 0.00% |
| LifePlan Financial Group, Inc | 1,440 | $1,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 4,806 | $4,000 | 0.00% |
| UBS Group AG | 105 | $0 | 0.00% |
| Sowell Financial Services LLC | 2,819 | $2,000 | 0.00% |
| IFP Advisors, Inc | 50 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 6 | $0 | 0.00% |
| Jacobi Capital Management LLC | 1,000 | $1,000 | 0.00% |